|Articles|December 16, 2014

Contagion

  • November 2014
  • Volume 1
  • Issue 3

Diarrhea Superbug Infections Double

From 2001 to 2010, the infection rate of a particular intestinal "superbug" has doubled, with increases in mortality rates and length of hospital stays reflecting this trend.

From 2001 to 2010, the infection rate of an intestinal superbug has doubled, with increases in mortality rates and length of hospital stays reflecting this trend, suggested research in the American Journal of Infection Control (AJIC).

Clostridium difficile (C. difficile) infections, which commonly induce diarrhea, has become a public health concern. Linked to 14,000 deaths annually, C. difficile is the top bacteria responsible for healthcare-associated infections.

Alarmingly, over-prescription of antibiotics is highly culpable for the increase of infections. According to the Centers for Disease Control and Prevention (CDC), a 30% decrease in the use of high-risk, broad-spectrum antibiotics would lower C. difficile infections (CDI) by 26%. As a result, the White House has prioritized re-educating clinicians on antibiotics, an Elsevier statement noted.

For their study, researchers conducted an analysis of US National Hospital Discharge Surveys from 2001-2010, and honed in on records involving CDIs.

Of the 2.2 million CDI discharges occurring during the study period, 33 and 67% of patients were treated for primary and secondary CDI, respectively.

“The overall in-hospital mortality rate was 7.1% (n=154,184) for the study period. Mortality increased slightly over the study period, from 6.6% in 2001 to 7.2% in 2010. Median hospital LOS was 8 days (interquartile range, 4-14 days), and remained stable over the study period,” the authors wrote.

Furthermore, lead author Kelly Reveles, PharmD, PhD said they found 2008 was the peak for CDI, with only a minor decline through 2010. Reveles attributed the decline to improved education new programs involving antibiotic prescription, infection control, and hygiene.

“The results of our study underscore the importance of directing resources to the prevention of CDI, as well as developing public policy for reducing the incidence of these in infections in hospitals worldwide,” the investigators said.


Related to this article

Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.